MD Anderson licenses OX40 antibodies to GSK

The University of Texas MD Anderson Cancer Center (Houston, Texas) granted GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) exclusive, worldwide rights to develop and commercialize antibodies that activate tum...